Brokerages Set The Cooper Companies, Inc. (NASDAQ:COO) Target Price at $90.15

by · The Markets Daily

Shares of The Cooper Companies, Inc. (NASDAQ:COO – Get Free Report) have been assigned an average rating of “Moderate Buy” from the sixteen research firms that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, five have given a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $90.1538.

A number of research firms recently weighed in on COO. Weiss Ratings restated a “sell (d+)” rating on shares of Cooper Companies in a research note on Monday. Citigroup reiterated a “neutral” rating and issued a $88.00 price target (up previously from $72.00) on shares of Cooper Companies in a research note on Monday, December 8th. The Goldman Sachs Group restated a “sell” rating and set a $71.00 price objective (up from $64.00) on shares of Cooper Companies in a research report on Monday, December 8th. JPMorgan Chase & Co. upped their target price on Cooper Companies from $66.00 to $78.00 and gave the company a “neutral” rating in a research report on Friday, December 5th. Finally, Stifel Nicolaus set a $95.00 price target on Cooper Companies and gave the stock a “buy” rating in a report on Friday, December 5th.

Get Our Latest Report on Cooper Companies

Insider Activity at Cooper Companies

In other Cooper Companies news, insider Holly R. Sheffield bought 1,230 shares of Cooper Companies stock in a transaction dated Tuesday, December 16th. The stock was bought at an average price of $80.75 per share, with a total value of $99,322.50. Following the completion of the transaction, the insider owned 39,052 shares in the company, valued at $3,153,449. The trade was a 3.25% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Cynthia L. Lucchese purchased 1,784 shares of the firm’s stock in a transaction that occurred on Monday, December 22nd. The stock was acquired at an average price of $84.06 per share, for a total transaction of $149,963.04. Following the completion of the purchase, the director directly owned 9,445 shares of the company’s stock, valued at $793,946.70. This represents a 23.29% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last ninety days, insiders have acquired 16,014 shares of company stock valued at $1,304,416. 1.98% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cooper Companies

Hedge funds and other institutional investors have recently made changes to their positions in the business. Cape Investment Advisory Inc. acquired a new stake in Cooper Companies during the third quarter worth approximately $66,000. Alecta Tjanstepension Omsesidigt lifted its position in shares of Cooper Companies by 15.8% during the 3rd quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock valued at $107,112,000 after acquiring an additional 213,500 shares during the period. Allworth Financial LP grew its holdings in shares of Cooper Companies by 23.9% during the 3rd quarter. Allworth Financial LP now owns 1,188 shares of the medical device company’s stock worth $81,000 after purchasing an additional 229 shares in the last quarter. IFP Advisors Inc increased its position in shares of Cooper Companies by 2,647.8% in the third quarter. IFP Advisors Inc now owns 632 shares of the medical device company’s stock worth $43,000 after purchasing an additional 609 shares during the period. Finally, Swiss Life Asset Management Ltd increased its position in shares of Cooper Companies by 63.9% in the third quarter. Swiss Life Asset Management Ltd now owns 49,409 shares of the medical device company’s stock worth $3,387,000 after purchasing an additional 19,264 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Stock Down 0.6%

Shares of COO stock opened at $81.96 on Thursday. Cooper Companies has a 52-week low of $61.78 and a 52-week high of $100.24. The stock has a market cap of $16.06 billion, a price-to-earnings ratio of 43.60, a PEG ratio of 2.36 and a beta of 1.05. The firm’s 50-day moving average is $76.36 and its 200-day moving average is $72.68. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89.

Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Cooper Companies declared that its board has authorized a stock repurchase program on Wednesday, September 17th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

Cooper Companies Company Profile

(Get Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

See Also